Product image of Miranax (Naproxen Sodium) supplied by GNH India

Miranax

Active Ingredient:
Naproxen Sodium
Origin:
EU

Miranax (Naproxen Sodium)

Naproxen sodium, the active ingredient in Miranax, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral formulation for systemic use. It is employed to alleviate pain and reduce inflammation in adult patients with musculoskeletal and inflammatory conditions.

GNH India supplies Miranax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to multiple regions. Customers benefit from reliable logistics and dedicated technical support throughout the procurement process.

Manufacturer / TM Owner

Grünenthal Österreich Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Miranax (naproxen sodium) acts as a non‑selective COX inhibitor and is indicated for several painful and inflammatory conditions.

  • Osteoarthritis: reduces joint pain and swelling, improving mobility.
  • Rheumatoid arthritis: alleviates chronic inflammation and joint discomfort.
  • Ankylosing spondylitis: diminishes spinal stiffness and pain.
  • Acute musculoskeletal pain: provides rapid relief of sprains, strains and back pain.
  • Dysmenorrhea: eases menstrual cramps and associated discomfort.
  • Gout flares: lessens pain and inflammation during acute attacks.

How It Works

  • Naproxen sodium inhibits both cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, decreasing the conversion of arachidonic acid to prostaglandins. The resulting reduction in prostaglandin synthesis diminishes inflammation, pain signaling, and fever generation throughout the body. By limiting prostaglandin‑mediated vasodilation and sensitization of nociceptors, naproxen sodium helps control edema and lowers the threshold for pain perception.

Side Effects

Naproxen sodium may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain.
  • Headache: mild to moderate intensity.
  • Dizziness: transient sensation of light‑headedness.

Serious or Rare Side Effects

  • Gastrointestinal ulceration or bleeding: potentially life‑threatening hemorrhage.
  • Renal impairment: reduced kidney function or acute kidney injury.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Precautions & Warnings

When prescribing naproxen sodium, clinicians should consider several precautionary measures to minimize risk.

  • Assess cardiovascular risk: evaluate history of heart disease or stroke before use.
  • Review gastrointestinal history: avoid in patients with active ulcers or bleeding disorders.
  • Monitor renal function: check creatinine levels in individuals with kidney impairment.
  • Use lowest effective dose: limit duration to the shortest period necessary for symptom control.
  • Avoid use in late pregnancy: contraindicated during the third trimester due to fetal risks.
  • Store at ambient temperature: keep below 25 °C in the original container, protected from moisture.

Avoid Interactions

Naproxen sodium can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): increased risk of serious bleeding.
  • Selective COX‑2 inhibitors (e.g., celecoxib): additive gastrointestinal toxicity.
  • High‑dose aspirin: heightened risk of ulceration and bleeding.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: may reduce antihypertensive effect and impair renal function.
  • Diuretics: potential for decreased kidney perfusion.
  • Lithium: naproxen may raise lithium serum concentrations.
  • Methotrexate: reduced clearance leading to toxicity.

Frequently Asked Questions

Miranax contains naproxen sodium, an NSAID indicated for the relief of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute musculoskeletal injuries, dysmenorrhea and gout flares. It is prescribed for adult patients when a non‑opioid analgesic and anti‑inflammatory option is appropriate.

Naproxen sodium blocks the activity of both COX‑1 and COX‑2 enzymes, which are required for the conversion of arachidonic acid into prostaglandins. By lowering prostaglandin levels, the drug reduces inflammation, pain signalling and fever, providing analgesic and anti‑inflammatory effects throughout the body.

The exact dose of Miranax is set by the prescribing healthcare professional based on the patient’s specific condition, severity of symptoms, age, renal and hepatic function, and any concomitant medications. Dosage adjustments may be required for elderly patients or those with organ impairment.

Safety data for naproxen sodium in pregnancy are limited, and the drug is generally avoided, especially in the third trimester because of potential fetal cardiovascular effects. Breastfeeding mothers should consult a physician, as naproxen can be excreted in milk and may affect the infant.

To request Miranax, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both Miranax (naproxen sodium) and ibuprofen are non‑selective NSAIDs, but naproxen has a longer half‑life, allowing less frequent dosing. Naproxen may provide more sustained pain control, whereas ibuprofen is often chosen for short‑term use. Individual response, safety profile and physician preference guide the choice.

Miranax should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Miranax is taken orally with a full glass of water. It may be taken with food or milk to reduce stomach upset. Patients should follow the prescriber’s instructions regarding timing, dose amount and duration of therapy.

Serious adverse events include gastrointestinal ulceration or bleeding, severe renal impairment, hepatotoxicity, cardiovascular events such as heart attack or stroke, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Any signs of severe bleeding, sudden kidney problems, or skin rash should prompt immediate medical attention.

Miranax is contraindicated in patients with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulceration or bleeding, severe heart failure, and in the third trimester of pregnancy. Caution is also advised for individuals with uncontrolled hypertension, severe renal or hepatic disease, and those taking anticoagulants.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Naproxen Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT